Ho Maykin insider trades
Ho Maykin has filed 23 Form 4s with the SEC that we hold, for Agios Pharmaceuticals, INC. (AGIO) (Director), Biomarin Pharmaceutical INC (BMRN) (Director), Kyntra Bio, INC. (KYNB) (Director) and Neumora Therapeutics, Inc. (NMRA) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $148.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 6,225 shares of Kyntra Bio, INC. worth $110.1K, dated 2023-06-08. The first filing on our record is dated 2022-05-24 and the latest 2026-06-23.
Agios Pharmaceuticals, INC. (AGIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Biomarin Pharmaceutical INC (BMRN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kyntra Bio, INC. (KYNB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-08 | S, sale reported on Form 4 | 6,225 | $110.1K | 2023-06-09 |
| 2023-06-08 | S, sale reported on Form 4 | 2,295 | $38.5K | 2023-06-09 |
Neumora Therapeutics, Inc. (NMRA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1646395) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms